Historic funding increase for CDC, $150 million proposed for Data Modernization
Council of State and Territorial Epidemiologists
May 28, 2021, 20:02 ET
ATLANTA, May 28, 2021 /PRNewswire/ — The Council of State and Territorial Epidemiologists (CSTE) applauds the Biden-Harris Administrations’s prioritization of public health, including data modernization to support disease surveillance via the recommendations released today in President Biden’s proposed Fiscal Year 2022 federal budget. These recommendations include:
$9.6 billion for the Centers for Disease Control and Prevention (CDC), a $1.7 billion increase over FY 2021 funding.
$150 million to support CDC’s Public Health Data Modernization Initiative. This investment aligns with the strategic goals of the Data: Elemental to Health campaign, which CSTE has spearheaded along with partners ASTHO, APHL, Big Cities Health Coalition, HIMSS, NAPHSIS, and NACCHO.
As our members continue the fight to eliminate COVID-19 on the front lines without access to modern, interoperable public health data systems, sustained funding for CDC data modernization efforts is more crucial than ever. CDC’s Data Modernization Initiative (DMI) has already begun to overhaul our nation’s data systems. The Administration’s proposal is an important step toward providing further annual resources to upgrade public health data infrastructure and speed our public health response. The proposed FY 2022 funding will help to move data modernization forward, but to truly transform our nation’s public health data infrastructure to support disease surveillance, we need a commitment to robust, sustained federal funding.
Founded in 1951, the Council of State and Territorial Epidemiologists (CSTE) represents the interests of State Epidemiologists from all 50 U.S. states and territories, comprising the Council. CSTE is also the professional home to more than 2000 practicing applied epidemiologists working at the state, local, tribal and territorial levels. For more information, visit www.cste.org.
Media Contact: Jeremy Arieh, Director of Communications, 770-458-3811, email: [email protected]
SOURCE Council of State and Territorial Epidemiologists
Newswise — Using data generated from patients and mice with genetic mutation for the disorder Usher syndrome, researchers from the University of Maryland School of Medicine (UMSOM), the National Institutes of Health’s National Eye Institute (NEI), and National Institute on Deafness and Other Communication Disorders (NIDCD), documented the natural history of vision impairment in patients…
Newswise — WASHINGTON—The rates of death and health burdens associated with air pollution are borne unequally and inequitably by people of color and those with lower household income and educational attainment in Washington, D.C., according to a new study.Air pollution is considered the leading environmental risk factor to health, and recent efforts have successfully brought…
For Immediate Release: November 05, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: Today, Friday, November 5, 2021, the FDA authorized another over-the-counter (OTC) COVID-19 test. The FDA issued an emergency use authorization (EUA) for the iHealth COVID-19 Antigen Rapid Test,…
Newswise — Clonal hematopoiesis, a condition in which mutations associated with blood cancers are found in the blood of healthy people, is common with aging. When looking for appropriate stem cell/bone marrow donors, clinicians tend to stay away from older donors with clonal hematopoiesis (CH) because of concerns about passing potentially premalignant stem cells to…
Today, the U.S. Food and Drug Administration authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age. The authorization was based on the FDA’s thorough and transparent evaluation of the data that included input from…